ClinicalTrials.gg
Status unknownNCT05641818Updated Dec 14, 2022

Challenges in Achieving Adequate Vitamin D Status in the Adult Population - Part 3 (VITAD/3)

An observational study in Vitamin D Serum Levels, sponsored by Nutrition Institute, Slovenia. Status unknown at 1 site in Slovenia. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-14.

Sponsored by Nutrition Institute, Slovenia · Observational

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
400
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Validation of a screening tool for identification of subjects at risk for suboptimal vitamin D status. Developed questionnaire-based screening tool will be used on subjects with various risks for vitamin D deficiency, and compared with 25-OH-vitamin D levels.

02

Conditions studied

  • Vitamin D Serum Levels
03

In context

Lead sponsor

Nutrition Institute, Slovenia is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Adult users and non-users of vitamin D drugs and food supplements living in Slovenia. Participants invited from the database at Nutrition Institute.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Signed form (ICF),
  • Age between 18 and 65 years at the time of the signature of Informed consent form (ICF),
  • Did not change use of vitamin D conatining drugs/supplements for last 6 weeks
  • Willingness to follow all study procedures

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding,
  • Change in use of food supplements containing Vitamin D in last 6 weeks
  • Acute ilness
  • Mental incapacity that precludes adequate understanding or cooperation.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
400 participants (estimated)
Patient registry
No

Interventions

  • OtherScreening tool for vitamin D deficiency

    (1) Determination of 25(OH) Vitamin D3 in human serum samples and (2) Question based screening tool with personal (age, gender,...), lifestyle (e.g. sun exposure, outdoor activity) and dietary factors that affect the status of vitamin D in the human body.

06

What researchers measure

Primary outcomes

  1. Difference between vitamin D status (deficiency) assessed by two different methods

    Vitamin D serum level will be measured for assessment of Vitamin D status. Risk for vitamin D deficiency will be assessed using questionaire-based screening tool. Two methods will be compared.

    Time frame: 1 year

07

Study locations

1 site
  • Nutrition Institute, Ljubljana
    Ljubljana, 1000, Slovenia
08

References and documents

Individual participant data

Plan to share: Undecided — Not decided yet

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05641818
Lead sponsor
Nutrition Institute, Slovenia
Collaborators
National Institute of Public Health, Slovenia, VIST - Faculty of Applied Sciences, Slovenian Research Agency
Responsible party
Sponsor
First posted
Dec 8, 2022
Start date
Dec 5, 2022
Primary completion
Oct 1, 2023 (estimated)
Completion
Dec 1, 2023 (estimated)
Last update
Dec 14, 2022

Study contacts

Igor Pravst, PhD
study chair · Institut za nutricionistiko
Katja Žmitek, PhD
principal investigator · VIST - Faculty of Applied Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion